Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter
Multielectrode Radiofrequency Balloon for Atrial Fibrillation Catheter Ablation: A Multicenter Real-World Experience
Universitair Ziekenhuis Brussel
2,000 participants
Jan 1, 2021
OBSERVATIONAL
Conditions
Summary
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.
Eligibility
Inclusion Criteria1
- symptomatic atrial fibrillation with indication to catheter ablation
Exclusion Criteria3
- age \<18 years old
- pregnancy
- any contraindications to catheter ablation
Interventions
Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06333327